Published in Gene Therapy Weekly, September 25th, 2003
This financial support, being part of the governmental Technical Development Project (TOP) regulation, reflects the strong commitment of the Dutch Ministry of Economic Affairs to support the development of AMT's IL-10 gene therapy program. The grant is repayable once revenues are generated from sales of ex vivo IL-10 gene therapy.
Ex vivo IL-10 gene therapy,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.